Jasper Bos, the former senior vice-president and managing director at M Ventures, a corporate venturing arm of pharmaceutical group Merck, has been appointed as a general partner at Netherlands-based venture capital firm Forbion.
Bos joined M Ventures, then known as Merck Serono Ventures, in 2009 and led a team of 21 investment professionals.
Bos has been involved in investment activities from seed stage deals to the supervision of four initial public offerings. He has supported investments in more than 50 companies in the technology, biotechnology and life science tool sectors.
Prior to joining M Ventures, Bos was an associate at the Investment Fund for Health in Africa and head of product development and business development at PharmAccess Foundation.
He also previously worked at the Netherlands Vaccine Institute and National Institute for Public Health and the Environment.
At Forbion, Bos will serve as a general partner for the firm’s $428m Forbion Growth Opportunities Fund I, which held a final close in April 2021.
The VC firm typically invests in life science companies operating in the biopharmaceutical sector.
Bos was an awardee in the Global Corporate Venturing Powerlist 2020.
Photo of Jasper Bos courtesy of LinkedIn